3 Patents
- US122031002025Development of Dengue Virus Vaccine Components
The Government Of The USA As Represented By The Secretary, Dept. Of Health And Human Services
0 cites - US117536272023Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in the 3′-UTR of Dengue Types 1,2,3, and 4, or Antigenic Chimeric Dengue Viruses 1,2,3, and 4
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
0 cites - US117463352023Development of Dengue Virus Vaccine Components
The Government Of The United States Of American, As Represented By The Secretary, Department Of Health And Human Services
0 cites